Johnson & Johnson Completes Acquisition of Shockwave Medical
Strengthens Position in Highest-Growth, Innovation-Oriented Segments of Cardiovascular Intervention Creates Greater Opportunity to Transform the Treatment Landscape for Cardiovascular Disease Johnson Johnson (NYSE: JNJ) today announced it has completed it...
Shockwave specializes in coronary artery disease (CAD) and peripheral artery disease (PAD) treatments. Its core products are its intravascular lithotripsy (IVL) devices, which are used to remove calcified plaques in arteries...ππ€
Problem reactionβ¦. PROFIT
The answer to heart disease is the treatment of scurvy- www.paulingtherapy.com